Nourish Secures $100M for Metabolic Health Clinic
Nourish’s Series C round was led by Menlo Ventures, with participation from Thrive Capital, Index…
Nourish’s Series C round was led by Menlo Ventures, with participation from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak and Operator Partners. The post Nourish Secures $100M for Metabolic Health Clinic appeared first on MedCity News.
A BioMarin Pharmaceutical drug met just one of two main goals of a Phase 3 test in a rare inherited enzyme deficiency with no FDA-approved therapies. The drug, a fusion protein, came from BioMarin’s 2025 acquisition of Inozyme Pharma. The post BioMarin’s Mixed Bag of Phase 3 Data Dim Prospects for Rare Disease Drug appeared…
Fountain Health Partners announced its launch, with plans to back startups approaching or already at profitability, with a clear three- to five-year path to a strategic exit. The investment firm was founded by Joey Campanelli, a former executive at Shields Health Solutions, and Jack Euston, a healthcare investment banker with more than a decade of…
This isn’t a supply problem. It’s a distribution problem. The physicians exist. The system just isn’t getting them where they need to be. The post Everyone’s Betting on AI to Solve the Physician Shortage —They’re Solving the Wrong Problem appeared first on MedCity News.
What sets vocal analysis apart is its simplicity and scale. Through a single 40‑second voice sample, multiple conditions can be screened simultaneously — no needles, no lab visits, and no physical presence required. The post The Future of Healthcare Screenings: The Power of Vocal Biomarkers appeared first on MedCity News.
Capital is flowing into the broader women’s health ecosystem at a pace we have not seen before. The practices that will capture value from that momentum are the ones that get their operational house in order now. The post Reducing Admin Waste in Women’s Health: The Financial Case for Upstream Workflows appeared first on MedCity…
At least, it won’t be overturned by the US Supreme Court. Endpoints reports: The Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare drug price negotiations. The justices declined to review multiple cases brought by AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Novo Nordisk, Novartis and Boehringer Ingelheim… The…
Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s…
GRAND JUNCTION, Colo. — Two state transportation workers were replacing a sign on the shoulder of U.S. Highway 6 in western Colorado one morning when a Jeep Grand Cherokee swerved off the road and struck them. The workers, Nathan Jones and Trent Umberger, died in the September 2024 crash, as did a passenger in the…
This analysis examines early indicators of how the expiration of enhanced premium tax credits has affected effectuated enrollment levels (i.e., enrollment among people who have paid their premiums), plan selections, and out-of-pocket costs in 2026, drawing on plan selection and effectuated enrollment data from the Centers for Medicare & Medicaid Services (CMS) and state-based Marketplace…